Anggot, Gregorio .

HRN: 01-24-46  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/19/2025
CEFTRIAXONE 1G (VIAL)
05/19/2025
05/26/2025
IV
2g
OD
CAP MR
Waiting Final Action 
05/19/2025
AZITHROMYCIN 500MG TABLET (TAB)
05/19/2025
05/24/2025
PO
500
OD
CAP MR
Waiting Final Action 
05/26/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
05/26/2025
06/09/2025
IV
4.5G
Q6H
HOSPITAL ACQUIRED PNEUMONIA
Waiting Final Action 
05/26/2025
LEVOFLOXACIN 500MG (TAB)
05/26/2025
06/02/2025
PO
500MG
OD
PNEUMONIA
Waiting Final Action 
06/08/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
06/08/2025
06/14/2025
IV
300mg
Q12H
E. Coli Pneumonia Infection
Remove - Pending Acceptance
06/10/2025
GENTAMICIN 40MG/ML, 2ML (AMP)
06/10/2025
06/16/2025
IV
240mg
Q24
Pneumonia - MDR
Remove - Pending Acceptance
06/15/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
06/15/2025
07/06/2025
IV
350mg
Q24h
CAP
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: